Paper Details

  1. Home
  2. Paper Details

Use of long-acting injectable buprenorphine in the correctional setting.

Author: BerkJustin, ClarkeJennifer G, FritscheJohn, KangAugustine, MartinRosemarie A, RichJosiah D

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, N.I.H., ExtramuralResearch funding provided by the NIH to external research institutions and researchers.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Extended-release buprenorphine (XR-BUP), a novel monthly injectable formulation for opioid use disorder (MOUD), could be a valuable tool to address treatment access limitations in correctional settings.
Paper Details　
Original Abstract of the Article :
As overdoses due to opioids rise, medications for opioid use disorder (MOUD) continue to be underemployed, resulting in limited access to potentially life-saving treatment. Substance use disorders are prevalent in individuals who are incarcerated, and these individuals are at increased risk for deat...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/35939914

データ提供：米国国立医学図書館（NLM）

Long-Acting Injectable Buprenorphine: A Promising Approach for Opioid Use Disorder in Correctional Settings

Opioid use disorder (OUD) poses a significant challenge, particularly within correctional settings. This article explores the potential of extended-release buprenorphine (XR-BUP), a novel monthly injectable formulation of the medication, to address the unique needs of this population. The authors highlight the critical role of medication-assisted treatment (MAT) in OUD management and the barriers to accessing these services, especially in correctional facilities.

The authors argue that XR-BUP, with its long-acting profile, could overcome many of these barriers. Its extended duration of action could simplify medication administration, reducing the logistical challenges of providing MAT in correctional settings. Additionally, it could enhance adherence to treatment, leading to improved outcomes for individuals with OUD.

Understanding Opioid Use Disorder: A Journey Through the Desert of Addiction

Imagine a vast desert, a landscape that can be both beautiful and unforgiving. Opioid use disorder, like a mirage shimmering on the horizon, can lead individuals down a treacherous path. This article, like a well-worn map, seeks to guide us toward a more compassionate and effective approach to treating this complex condition.

Dr. Camel's Conclusion

This article presents a compelling case for the use of XR-BUP in correctional settings, highlighting its potential to address the unique challenges of OUD management in this population. The authors advocate for a shift towards more accessible and effective MAT programs, recognizing the crucial role of these therapies in helping individuals break free from the grip of addiction.

Date :
  1. Date Completed 2022-09-28
  2. Date Revised 2023-11-02
Further Info :

Pubmed ID

35939914

DOI: Digital Object Identifier

NIHMS1851312

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.